Status:
UNKNOWN
Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities
Lead Sponsor:
Ahmed A. H. Abdellatif
Conditions:
Skin and Subcutaneous Tissue Disorders
Eligibility:
All Genders
50-70 years
Phase:
PHASE1
Brief Summary
As the quality of life improves, people are seeking to look as young as they feel. Ginkgo biloba (GB) and Pomegranate (PG) extract can be used to create efficacious topical anti-aging products. GB \& ...
Detailed Description
In this study, a vanishing cream will be prepared by reaction of a stearic acid with alkali (NaOH) to form stearate soap. Then the GB extract will be added to the final form. The formulated cream will...
Eligibility Criteria
Inclusion
- Clinical diagnosis of aging shape
- Follow up and collect data for a local and systemic activity of Ginkgo Biloba and Pomegranate
- The skin should be not injured as the cream can be easily applied
- Systemic oral capsule Ginkgo Biloba and Pomegranate can be also given to enhance the activity as anti-aging activity
Exclusion
- Insulin-dependent diabetes
- Hypertension disease
- Skin wound
Key Trial Info
Start Date :
May 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03772418
Start Date
May 18 2018
End Date
February 28 2020
Last Update
December 11 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut Clinic
Asyut, Egypt, 71526
2
Faculty of Pharmacy
Buraidah, Al-Qassim Region, Saudi Arabia, 51452
3
Pharmaceutics dept., Faculty of Pharmacy, Qassim University
Buraidah, Al-Qassim Region, Saudi Arabia, 51452